marks published for opposition - U.S. Patent and Trademark Office

TM 400 OFFICIAL GAZETTE DEC 4, 2012
CLASS 5—(Continued).
SN 77-114,137. ANACOR PHARMACEUTICALS, INC., PALO
ALTO, CA. FILED 2-22-2007.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
OWNER OF U.S. REG. NOS. 3,815,813 AND 3,826,470.
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF FUNGAL, AUTO-IMMUNE, INFLAM-
MATORY, INFECTIOUS, BACTERIAL, PARASITIC, VIR-
AL, ONCOLOGIC AND OPHTHALMIC DISEASES AND
CONDITIONS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).
JENNY PARK, EXAMINING ATTORNEY
SN 77-114,145. ANACOR PHARMACEUTICALS, INC., PALO
ALTO, CA. FILED 2-22-2007.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
OWNER OF U.S. REG. NOS. 3,815,813 AND 3,826,470.
NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO
USE "PHARMACEUTICALS", APART FROM THE MARK
AS SHOWN.
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF FUNGAL, AUTO-IMMUNE, INFLAM-
MATORY, INFECTIOUS, BACTERIAL, PARASITIC, VIR-
AL, ONCOLOGIC AND OPHTHALMIC DISEASES AND
CONDITIONS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).
JENNY PARK, EXAMINING ATTORNEY
SN 79-101,871. MEGGLE AG, FED REP GERMANY, FILED
7-20-2011.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
OWNER OF INTERNATIONAL REGISTRATION 1088871
DATED 7-20-2011, EXPIRES 7-20-2021.
FOR LACTOSE FOR PHARMACEUTICAL USE (U.S.
CLS. 6, 18, 44, 46, 51 AND 52).
TRACY FLETCHER, EXAMINING ATTORNEY
CLASS 5—(Continued).
SN 79-101,876. MEGGLE AG, FED REP GERMANY, FILED
7-20-2011.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
OWNER OF INTERNATIONAL REGISTRATION 1088878
DATED 7-20-2011, EXPIRES 7-20-2021.
THE WORDING "INHALAC" HAS NO MEANING IN A
FOREIGN LANGUAGE.
FOR LACTOSE FOR PHARMACEUTICAL AND VE-
TERINARY PURPOSES (U.S. CLS. 6, 18, 44, 46, 51 AND
52).
TRACY FLETCHER, EXAMINING ATTORNEY
SN 79-111,162. JEAN MARIE RAYMOND, SPAIN, FILED 1-
11-2012.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
OWNER OF INTERNATIONAL REGISTRATION 1111760
DATED 1-11-2012, EXPIRES 1-11-2022.
FOR DIETETIC SUBSTANCES, NAMELY, ANTIOXI-
DANT COMPOUNDS ADAPTED FOR MEDICAL USE
(U.S. CLS. 6, 18, 44, 46, 51 AND 52).
WILLIAM JACKSON, EXAMINING ATTORNEY
SN 79-111,454. CAREGEN CO.,LTD., REPUBLIC OF KOREA,
FILED 2-2-2012.
PRIORITY DATE OF 9-9-2011 IS CLAIMED.
OWNER OF INTERNATIONAL REGISTRATION 1112389
DATED 2-2-2012, EXPIRES 2-2-2022.
THE MARK CONSISTS OF THE WORDING "REVOFIL"
IN A STYLIZED FONT.
FOR PHARMACEUTICAL PRODUCTS ADMINIS-
TERED BY INJECTION FOR USE IN MOISTURIZING
SKIN AND REDUCING WRINKLES (U.S. CLS. 6, 18, 44,
46, 51 AND 52).
ALLISON SCHRODY, EXAMINING ATTORNEY